Medication info
Diabetes Tablet 50 mg (Vildagliptin)

Diabetes Tablet 50 mg (Vildagliptin)

Prescription medicationTabletOral
Ingredient · strength
Vildagliptin›50mg / 1 tablet
Manufacturer / importer
Hanmi Pharmaceutical Co., Ltd.
Appearance
White to light yellow round tablet
Packaging
28 tablets/box [14 tablets/PTP (x2)]
Approval status
Active

MFDS item code 202108196 · Approved 2021.12.29 · Insurance code 649105420

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
For monotherapy or in patients with no prior experience of antidiabetic drug therapy, when administered in combination with metformin, this medicine is administered at a dose of 50mg once daily in the morning or 100mg per day, divided into 50mg twice daily in the morning and evening. When adequate glycemic control cannot be achieved with metformin or thiazolidinedione monotherapy, the recommended dose of this medicine when administered in combination with metformin or a thiazolidinedione is 100mg per day, divided into 50mg twice daily in the morning and evening. When adequate glycemic control cannot be achieved with sulfonylurea monotherapy, the recommended dose of this medicine when administered in combination with a sulfonylurea is 50mg once daily in the morning. In this patient group, vildagliptin 100mg once daily was not more effective than 50mg once daily. When adequate glycemic control cannot be achieved with combination therapy of a sulfonylurea and metformin, the recommended dose of this medicine when used as add-on combination therapy (triple therapy) is 100mg per day, divided into 50mg twice daily in the morning and evening. When adequate glycemic control cannot be achieved with insulin therapy (insulin alone or in combination with metformin), the recommended dose of this medicine when administered concomitantly is 100mg per day, divided into 50mg twice daily in the morning and evening. This medicine may be taken with or without food, and doses greater than 100mg per day are not recommended. When this medicine is used in combination with a sulfonylurea, a reduction in the sulfonylurea dose may be necessary to reduce the risk of hypoglycemia. If you forget to take this medicine, take it as soon as you remember and take the next dose at the usual time. If you remember close to the time of your next dose, skip the missed dose. Do not take a double dose at one time to make up for a missed dose. Patients with hepatic impairment Use is not recommended in patients with hepatic impairment whose ALT or AST levels exceed 2.5 times the upper limit of normal before starting this medicine. Patients with renal impairment Mild renal impairment (creatinine clearance ≥50mL/min): No dosage adjustment is required. Moderate or severe renal impairment or end-stage renal disease (ESRD): Administration of 50mg once daily is recommended. (See section 2) under 3. General Precautions in Precautions for Use.)

Ingredients

Manufacturer
Hanmi Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Difficulty in controlling blood sugar levels in patients with Type 2 diabetes
View approved original text

This medication is used alongside diet and exercise to help control blood sugar levels in patients with Type 2 diabetes. It can be used alone for initial treatment, or in combination with other diabetes medications such as metformin, sulfonylurea, or thiazolidinediones when monotherapy is insufficient. It can also be administered together with insulin therapy in patients who struggle to control blood sugar levels. This approach effectively manages blood sugar levels and aids in diabetes treatment.

How to take

Adult dose

For monotherapy or in patients with no prior experience of antidiabetic drug therapy, when administered in combination with metformin, this medicine is administered at a dose of 50mg once daily in the morning or 100mg per day, divided into 50mg twice daily in the morning and evening. When adequate glycemic control cannot be achieved with metformin or thiazolidinedione monotherapy, the recommended dose of this medicine when administered in combination with metformin or a thiazolidinedione is 100mg per day, divided into 50mg twice daily in the morning and evening. When adequate glycemic control cannot be achieved with sulfonylurea monotherapy, the recommended dose of this medicine when administered in combination with a sulfonylurea is 50mg once daily in the morning. In this patient group, vildagliptin 100mg once daily was not more effective than 50mg once daily. When adequate glycemic control cannot be achieved with combination therapy of a sulfonylurea and metformin, the recommended dose of this medicine when used as add-on combination therapy (triple therapy) is 100mg per day, divided into 50mg twice daily in the morning and evening. When adequate glycemic control cannot be achieved with insulin therapy (insulin alone or in combination with metformin), the recommended dose of this medicine when administered concomitantly is 100mg per day, divided into 50mg twice daily in the morning and evening. This medicine may be taken with or without food, and doses greater than 100mg per day are not recommended. When this medicine is used in combination with a sulfonylurea, a reduction in the sulfonylurea dose may be necessary to reduce the risk of hypoglycemia. If you forget to take this medicine, take it as soon as you remember and take the next dose at the usual time. If you remember close to the time of your next dose, skip the missed dose. Do not take a double dose at one time to make up for a missed dose. Patients with hepatic impairment Use is not recommended in patients with hepatic impairment whose ALT or AST levels exceed 2.5 times the upper limit of normal before starting this medicine. Patients with renal impairment Mild renal impairment (creatinine clearance ≥50mL/min): No dosage adjustment is required. Moderate or severe renal impairment or end-stage renal disease (ESRD): Administration of 50mg once daily is recommended. (See section 2) under 3. General Precautions in Precautions for Use.)

Precautions

This medication should not be administered to certain patients. Patients who are allergic to the active ingredient or any other components, those with Type 1 diabetes, or those with diabetic ketoacidosis should not take this medication. Additionally, it contains lactose, and patients with lactose intolerance or related genetic disorders should also avoid taking it. While taking this medication, mild adverse reactions may occur, which are mostly temporary and not serious enough to warrant discontinuation. Since there is a possibility of liver function abnormalities, it is important to undergo regular liver function tests. If liver enzyme levels rise significantly or if symptoms of jaundice appear, the medication should be stopped immediately. This medication can rarely cause allergic reactions such as angioedema or skin rashes, which may necessitate medical attention in severe cases. There is also a risk of acute pancreatitis, so if symptoms such as abdominal pain, nausea, or vomiting occur, immediate contact with healthcare professionals is required. When used in combination with other medications for diabetes treatment, there may be an increased risk of hypoglycemia, so it's essential to monitor for symptoms of low blood sugar closely. Symptoms such as dizziness or headache may occur, so it is advisable to avoid driving or operating machinery when experiencing these symptoms. It is recommended not to use this medication during pregnancy or while breastfeeding, and its use is not recommended for children or adolescents under the age of 18. Special dosage adjustments are not required for elderly patients. In case of overdose, specific antidotes are not available, and supportive treatment based on symptoms is needed, as this medication cannot be removed through dialysis. This medication should be kept out of the reach of children, and caution should be taken as transferring it to other containers may not preserve the quality of the medication.

Side effects

  • hepatitis
  • abnormal liver function
  • elevated transaminase levels
  • angioedema
  • tremors
  • headache
  • dizziness
  • fatigue
  • nausea
  • hypoglycemia
Show 64 more
  • pharyngitis
  • asthenia
  • constipation
  • weight gain
  • peripheral edema
  • gastroesophageal reflux
  • diarrhea
  • bloating
  • chills
  • decreased blood sugar
  • hyperhidrosis
  • pancreatitis
  • urticaria
  • blisters
  • exfoliative skin lesions
  • severe arthralgia
  • cutaneous vasculitis
  • cholecystitis
  • acute myocardial infarction
  • nodular arrhythmia
  • acute cholecystitis
  • pneumothorax
  • cholelithiasis
  • femoral fracture
  • peripheral artery occlusive disease
  • supraventricular tachycardia
  • congestive heart failure
  • gastric ulcer
  • stomach cancer
  • increased INR
  • appendicitis
  • pulmonary edema
  • dizziness
  • chest discomfort
  • dyspnea
  • cough
  • indigestion
  • drowsiness
  • pruritus
  • dry mouth
  • vomiting
  • insomnia
  • renal impairment
  • lip blisters
  • hunger
  • sensory loss
  • spinal canal stenosis
  • abdominal pain
  • gastroenteritis
  • gastritis
  • gastric ulcer
  • belching
  • appendicitis
  • fatty liver
  • hyperkalemia
  • hypertriglyceridemia
  • heart failure
  • cardiomegaly
  • angina pectoris
  • cardiac arrest
  • renal cyst
  • lung cancer
  • leg pain
  • increased C-reactive protein

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture, so it should be stored in a tightly sealed container. Also, it should be kept in a cool place below 30 degrees Celsius to maintain its efficacy.

Appearance and packaging

Appearance

White to light yellow round tablet

Package unit

28 tablets/box [14 tablets/PTP (x2)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.